Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             474 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 AAV2-GDNF Gene Delivery in Mild- and Moderate-Stages of Parkinson’s Disease: Preliminary Brain Imaging and Clinical Outcomes Van Laar, A.

122 C p.
artikel
2 Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: Evidence from meta-analysis and Mendelian randomization studies Deng, J.-Y.

122 C p.
artikel
3 A case of late onset PLA2G6-Associated neurodegeneration (Plan) with parkinsonism Pak, T.

122 C p.
artikel
4 A case of Parkinsonism with Niemann-Pick Type C Heterozygous Mutation Bildirici, Ş.

122 C p.
artikel
5 A case report of acute thrombocytopenia induced by Apomorphine in a patient with Parkinson's disease with motor fluctuations Pocora, M.M.

122 C p.
artikel
6 Accelerometric quantification of MDS-UPDRS bradykinesia measurements in PD patients: A pilot study Smid, A.

122 C p.
artikel
7 Accurate assessment of balance dysfunction in Parkinson's disease at different periods with Balance instruments Zhao, Q.

122 C p.
artikel
8 A comprehensive evaluation of the non-motor symptoms, quality of life and caregiver burden in patients with idiopathic dystonia Gowda, N.

122 C p.
artikel
9 Acute effect of levodopa on orthostatic hypotension and its association with motor responsiveness in Parkinson's disease Liu, Z.

122 C p.
artikel
10 Acute effect of levodopa on orthostatic hypotension and its association with motor responsiveness in Parkinson's disease Liu, Z.

122 C p.
artikel
11 Addressing Brain Circuit Dysfunction Underlying DBS-induced Parkinsonism Martins, D.

122 C p.
artikel
12 A Diagnostic Model for Parkinson’s Disease Based on Anoikis-Related Genes Bao, Y.

122 C p.
artikel
13 Adult-onset craniocervical dystonia associated with a monoallelic pathogenic AP4M1 variant and brain iron accumulation: A case report Testini, P.

122 C p.
artikel
14 Adult-onset dystonic opisthotonus associated with DLG4-related synaptopathy De Santis, T.

122 C p.
artikel
15 Advanced perspectives for the diagnosis of Parkinson’s and Alzheimer's disease through machine learning techniques Malvaso, A.

122 C p.
artikel
16 Age-related incidence of Parkinson's disease patients with Covid-19 Salimjonov, J.

122 C p.
artikel
17 Age-specific prevalence of Parkinson’s disease and possible parkinsonian syndrome in Gaucher disease: Real-world evidence from the ICGG Gaucher Registry Alcalay, R.N.

122 C p.
artikel
18 A late-preterm neonate with germinal matrix hemorrhages and rapidly resolving abnormal vertical eye movements Rachão, A.

122 C p.
artikel
19 Alterations of neurotransmitters and metabolite levels in a rat model of orofacial dyskinesia Kumar, A.

122 C p.
artikel
20 A mouse model of Parkinson’s disease to understand the sex differences in pathological and behavioral outcomes Subramanya, S.K.

122 C p.
artikel
21 Analgesic effect of electroacupuncture on pain in Parkinson's disease and mechanism based on rs-fMRI Zhu, S.

122 C p.
artikel
22 Analysis of Parkinson's disease patients with Covid-19 by age and sex Muminov, B.

122 C p.
artikel
23 Analysis of risk factors affecting the development of vascular parkinsonism by gender Amonov, B.

122 C p.
artikel
24 An atypical case of head tremor Angeloni, B.

122 C p.
artikel
25 A new mutation for SCA38 or a huge coincidence? Wiens, J.

122 C p.
artikel
26 An observational study of Quality of Life in patients with Parkinson’s Disease pre and post DBS Jayasree, M.

122 C p.
artikel
27 An open-label, randomized, crossover, comparative bioavailability study of Levodopa Cyclops® and Inbrija® in healthy adult subjects Hoppentocht, M.

122 C p.
artikel
28 Anterior Attentional System Functioning in Patients with Parkinson’s Disease Across Various Cognitive Statutes Golińska, P.

122 C p.
artikel
29 Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work? del Giudice, Kirsys Patricia

122 C p.
artikel
30 Anti-CASPR2 antibody-associated syndrome presenting with episodic ataxia Lopes, S.

122 C p.
artikel
31 An unsteady tale Garg, D.

122 C p.
artikel
32 An unusual cause of gait disturbance in a patient with Parkinson’s disease: Beware of mimics and chameleons Fernandes, A.

122 C p.
artikel
33 Application of motor rehabilitation programs in the normalization of the psycho-emotional sphere of patients with Parkinson`s disease Voloshyn-Haponov, I.

122 C p.
artikel
34 A prediction model for the progression of blepharospasm: A 4-year prospective cohort study Xing, Z.

122 C p.
artikel
35 A rare case of reversible hemidystonia in chronic hypoparathyroidism with extensive cerebral calcification Kim, C.-W.

122 C p.
artikel
36 Are genetic studies in Parkinson's disease necessary in clinical practice? Preliminary report of a cohort from Buenos Aires Espindola, M.

122 C p.
artikel
37 Are LRRK2 p.G2019S or GBA1 variants associated with long-term outcomes of deep brain stimulation for Parkinson’s disease? Anis, S.

122 C p.
artikel
38 Are peripheral α-synuclein isoforms biomarkers for diagnosis and prognosis of isolated REM sleep behavior disorder? Arnaldo, L.

122 C p.
artikel
39 Are the 5-2-1 Delphi criteria and MANAGE-PD useful screening tools for qualification to device-added therapies in advanced Parkinson’s disease? Duda, K.

122 C p.
artikel
40 Are there gender differences between subthalamic or globus pallidus internus DBS in Parkinson’s disease? Results from a single center Belluscio, G.

122 C p.
artikel
41 Associated Factors of Depression and Anxiety in Patients with Parkinson’s Disease Ay, E.

122 C p.
artikel
42 Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment Kim, J.-S.

122 C p.
artikel
43 Association between autoimmune diseases and the risk of incident Parkinson's disease Shang, H.

122 C p.
artikel
44 Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease Kwon, K.-Y.

122 C p.
artikel
45 Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease Kwon, K.-Y.

122 C p.
artikel
46 Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder Sun, Y.

122 C p.
artikel
47 Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease Kim, S.J.

122 C p.
artikel
48 Association of Glycated Hemoglobin (HbA1c) levels with Motor Symptoms in Parkinson’s Disease: A Cross-Sectional Investigation in the Indian Population Choudhary, N.

122 C p.
artikel
49 Association of small right vagus nerve cross-sectional area with abnormal heart rate variability Lee, J.

122 C p.
artikel
50 Asterixis resulting from neurosurgery Palacino, F.

122 C p.
artikel
51 A structural perspective on the interaction between glucocerebrosidase and the positive allosteric modulator BIA 28-6156 Dantas, J.M.

122 C p.
artikel
52 Ataxia in Northern Canada: A Genetic Case Study Villa Lopez, M.

122 C p.
artikel
53 A Unique Case of Episodic Ataxia in SCA45: Unveiling a Novel FAT2 Variant Makharia, A.

122 C p.
artikel
54 Automated detection of REM Sleep Without Atonia: Description and Technical Evaluation Levendowski, D.

122 C p.
artikel
55 Autonomic dysfunction and motor progression in multiple system atrophy: A 1-year prospective cohort study Huang, J.

122 C p.
artikel
56 Baseline lipid traits and the clinical characteristics and disease progression in Huntington’s disease Zhang, S.

122 C p.
artikel
57 Blood Cholesterol Levels of Parkinson's Disease patients in Taksim Research and Training Hospital in İstanbul, Turkey Tüncer, E.N.

122 C p.
artikel
58 Botulinum toxin administration in Parkinson's Disease: Lateral trunk flexion suggesting early Pisa Syndrome Cenacchi, V.

122 C p.
artikel
59 Brain-first vs. body-first Parkinson's disease: An update on recent evidence Horsager, Jacob

122 C p.
artikel
60 Brain metabolic correlates of STN-DBS on gait in Parkinson’s disease: FDG-PET study of gait with dynamic obstacle avoidance Hanafi, I.

122 C p.
artikel
61 Burden and management of tardive dyskinesia (TD): An international survey to assess the perceptions and experiences of patients with TD Ribalov, R.

122 C p.
artikel
62 Burden, anxiety and depression among caregivers of Parkinson's patients Alshoumar, A.

122 C p.
artikel
63 Calcium channel blockers and Parkinson's disease: A systematic review and meta-analysis Lin, J.

122 C p.
artikel
64 Can a specific deep brain stimulation paradigm slow motor progression and provide long-term motor benefit in Parkinson’s disease? Hacker, M.L.

122 C p.
artikel
65 Can Baseline Diffusion Tensor Imaging Analysis Along the Perivascular Space Predict Motor Progression at 5 Years in Parkinson Disease? Assaedi, E.

122 C p.
artikel
66 Can α-synuclein oligomers in skin biopsies predict the worsening of cognition in Parkinson’s disease? A single-center longitudinal cohort study Contaldi, E.

122 C p.
artikel
67 Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism Bhargava, R.

122 C p.
artikel
68 β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome Rubalcava, P.A. Brand

122 C p.
artikel
69 Case Report: Jaw opening oromandibular dystonia with good response to isolated bilateral genioglossus botulinum toxin type A injections Anang, J.

122 C p.
artikel
70 Case report of a Parkinson’s disease patient with early motor fluctuation Park, S.

122 C p.
artikel
71 CasRm-mediated PTBP1 Knockdown Improves Motor Functions in Parkinson's Disease Mouse and Non-human Primate Models Wang, S.

122 C p.
artikel
72 Caudate dopamine loss, occipital hypoperfusion, and dementia conversion in Parkinson’s disease: A dual-phase 18F-FP-CIT PET Study Chung, S.J.

122 C p.
artikel
73 Cerebellar Ataxia, Parkinsonism and Peripheral Neuropathy in an Indian Family with MME Mutation Desai, S.

122 C p.
artikel
74 Cerebellar symptomatology following Covid-19 vaccination reveals breast cancer Trpcheski, F.

122 C p.
artikel
75 Cerebellopontine Angle Tumor Presenting with Hemifacial Spasm Attacks Isiklar, C.O.

122 C p.
artikel
76 Cerebrotendinous Xanthomatosis: Understanding Neurological Manifestations Through Physical Exam Video Lopez, M. Villa

122 C p.
artikel
77 Challenges during prayer (namaz/salah) rituals in Muslim patients with Parkinson’s disease Çelik, B.

122 C p.
artikel
78 Changes in NO-system parameters in vascular parkinsonism Juraev, R.

122 C p.
artikel
79 Changes of motor symptoms and regional cerebral blood flow after transcranial direct current stimulation in Parkinson's disease Hwang, E.

122 C p.
artikel
80 Changes of vagus nerve cross-sectional area as a disease-specific imaging biomarker in early Parkinson’s disease patients Kang, J.H.

122 C p.
artikel
81 Characterization of movement disorders in a cohort of hereditary cerebellar ataxias Costa, S.

122 C p.
artikel
82 Characterization of the pattern of daily motor fluctuations in Parkinson’s disease patients based on home diaries Hauser, R.A.

122 C p.
artikel
83 Characterizing Pain in Parkinson's Disease: Unveiling Types and Underlying Pathophysiology through a Scoping Review Desai, D.

122 C p.
artikel
84 Chorea-Acanthocytosis: A Case Report Demir, S.

122 C p.
artikel
85 Clinical – anatomical correlation of anti-dystonic effect in pallidal stimulation by advanced image reconstruction Bejarano Hernandez, J.A.

122 C p.
artikel
86 Clinical and genetic characteristics of PLA2G6-parkinsonism in southwest China and a review of heterogeneity of phenotype and genotype between Asian and Caucasian patients Cheng, Y.

122 C p.
artikel
87 Clinical and genetic factors affecting response to amantadine in Parkinson patients: Experience from a single tertiary center Saadatpour, L.

122 C p.
artikel
88 Clinical characteristics and mortality in Parkinson's disease patients with a history of fractures Tawara, N.

122 C p.
artikel
89 Clinical Evaluation of Parkinson's Disease Patients Admitted to the Movement Disorders Outpatient Clinic of Istanbul Taksim Training and Research Hospital, Turkey, 2023 Okutan, A.E.

122 C p.
artikel
90 Clinical Overlap of Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) and Movement Disorders: Impact of Misdiagnosis on a Patient’s Journey Meier, A.

122 C p.
artikel
91 Clinical Phenomenology of Idiopathic and Acquired Adult-Onset Oromandibular Dystonia: From Onset to Spread Trinchillo, A.

122 C p.
artikel
92 Clinical profile of parkinsonism by molecular imaging of the brain (TRODAT and PET-CT) Lavania, S.

122 C p.
artikel
93 Clinical response and reduction in medication use after DBS surgery in a group of patients with Parkinson's disease in Colombia López, T.

122 C p.
artikel
94 Clinometric Profile of the Korean Version of Cognition Scales for Outcomes in Parkinson’s Disease Park, J.

122 C p.
artikel
95 Cognition in Multiple System Atrophy patients: The impact of sex and motor phenotype Lazzeri, G.

122 C p.
artikel
96 Cognition of Parkinson’s Disease Patients in the On and Off State: A Case Series Brillman, S.

122 C p.
artikel
97 Cognitive compromise in a cohort of patients from Colombia with DBS for Parkinson's disease treatment López, T.

122 C p.
artikel
98 Cognitive impairment in Parkinson's disease Akbaralieva, S.

122 C p.
artikel
99 Cognitive impairment in the underrepresented Latinx Parkinson disease population – Insights from the LARGE-PD and PPMI cohorts Anis, S.

122 C p.
artikel
100 Combined Assessment of GCase Activity and α-synuclein as a Promising Blood Biomarker for GBA Mutation Carriers Pasquini, C.

122 C p.
artikel
101 ‘Comb sign' in mitochondrial membrane protein associated neurodegeneration: Revelation from 5 cases Agarwal, A.

122 C p.
artikel
102 Communication in Parkinson’s Disease and Healthy Controls: A Mixed-Methods Exploration of Conversational Speech Recordings in Natural Environments Rountrey, C.

122 C p.
artikel
103 Community-based participatory research approach to address health care disparities confronting members of the Black Diaspora with Parkinson’s disease Pacheco, A.

122 C p.
artikel
104 Comparative analysis of timings and errors in movements associated with Go and No-Go signals in Parkinson’s disease Singh, H.

122 C p.
artikel
105 Comparative profile of neurocognition and quality of life in Parkinson’s disease with and without psychosis Baruah, T.

122 C p.
artikel
106 Comparing brain activation in two subtypes of task-specific focal dystonia during dystonia-related and unrelated tasks: An fMRI study Huynh, B.P.

122 C p.
artikel
107 Comparison of spontaneous brain activity in distinguishing the parkinsonian variant of multiple system atrophy from Parkinson's disease at an early stage Wang, S.

122 C p.
artikel
108 Comprehensive analysis of information processing speed components in patients with Parkinson's disease Alonso-Recio, L.

122 C p.
artikel
109 Computational studies of compounds against alpha-synuclein in Kampavata AKA Parkinson's disease in Ayurveda Rajpoot, S.

122 C p.
artikel
110 Continuous subcutaneous levodopa/carbidopa infusion (ND0612) for patients with Parkinson’s disease and motor fluctuations: A Phase 3, active-controlled study (BouNDless) Stocchi, F.

122 C p.
artikel
111 Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson’s disease: Three-year data from the open-label BeyoND study Stocchi, F.

122 C p.
artikel
112 Could Irritable Bowel Syndrome be a Prodrome to Parkinson’s Disease? A Systematic Review Lim, Y.L.

122 C p.
artikel
113 Craniocervical synkinesias in movement disorder patients Van Midden, V.M.

122 C p.
artikel
114 CVN424, A novel GPR6 inverse agonist for the treatment of Parkinson disease (PD): Phase 2 clinical trial Kieburtz, K.

122 C p.
artikel
115 Dancing Out of Step: A Case of Tuberculous Meningitis Disguised as Childhood Chorea Garcia, J.J.

122 C p.
artikel
116 Deep Brain Stimulation of the Posterior Hypothalamus in Aggression Management – A Case Series Analysis Poveda, S.

122 C p.
artikel
117 Deep learning-based automatic REM sleep detection in patients with REM sleep behavior disorder: Is it reliable? Jung, Y.J.

122 C p.
artikel
118 Delphi Analysis: Anatomy and Botulinum Neurotoxin Type-A (BoNT-A) Injection Training for Spasticity and Dystonia Heckert, K.

122 C p.
artikel
119 Depressive disorder in Parkinson's disease Akbaralieva, S.

122 C p.
artikel
120 Depressive symptoms in advanced Parkinson`s disease Petrić, D.

122 C p.
artikel
121 Determination of Ambroxol Levels in Plasma and Cerebrospinal Fluid by Online Solid-Phase Extraction Coupled with Liquid Chromatography-Tandem Mass Spectrometry in GBA-Parkinson Disease Patients Franco, V.

122 C p.
artikel
122 Determination of hyperkinetic movement disorders during and after acute stroke Qarshiboyeva, N.

122 C p.
artikel
123 Developing and validating the new screening questionnaire for prodromal and Parkinson’s disease Sringean, J.

122 C p.
artikel
124 Development of a screening AI model for Parkinson's disease using gait image sequences Youn, J.

122 C p.
artikel
125 Diagnostic value and correlation analysis of serum cytokine levels in patients with multiple system atrophy Chen, X.

122 C p.
artikel
126 Differences in Dopamine Transporter Loss Pattern by DaTscan among patients with Parkinson's disease, Dementia with Lewy bodies and Parkinson's disease with dementia Senoo, H.

122 C p.
artikel
127 Differences in sleep behavior disorders between clinical types of idiopathic Parkinson’s disease Lou, F.

122 C p.
artikel
128 Differential roles of regional enlarged perivascular spaces in cognition and neuropsychiatric burden in drug-naive Parkinson’s disease Na, H.K.

122 C p.
artikel
129 Differential symptom cluster responses and predictors of response to repetitive transcranial magnetic stimulation treatment in Parkinson’s disease: A retrospective study Sun, J.

122 C p.
artikel
130 Digital devices and wearable technology for quantification of freezing of gait in adolescents with pediatric movement disorders attending school Sharma, V.

122 C p.
artikel
131 Disruption of the respiratory chain in the mitochondria of muscle cells in Parkinson’s disease Abdiyeva, D.

122 C p.
artikel
132 Does Deep Brain Stimulation worsen cognitive decline in GBA-Parkinson Disease patients? A longitudinal study of the Italian PARKNET cohort AVENALI, M.

122 C p.
artikel
133 Do lower doses of botulinum toxin offer a longer duration of effect and superior efficacy in patients with cervical dystonia? Kundrick, A.

122 C p.
artikel
134 Dopamine receptor D2 on CD4+ T cells is protective against neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease Qiu, Y.-H.

122 C p.
artikel
135 Dopaminergic System Changes in Visuomotor-Cognitive Multitasking Simulating Real-Life Mobility in Parkinson’s Disease Bohnen, N.

122 C p.
artikel
136 Dural arteriovenous fistula initially presenting as reversible asymmetric parkinsonism and improvement on dopamine transporter imaging after endovascular embolization treatment Yoon, W.T.

122 C p.
artikel
137 Duration of Botulinum Toxin Efficacy in Cervical Dystonia Clinical Trials: A Narrative Review Castagna, A.

122 C p.
artikel
138 Dystonia in the Middle East - The Cleveland Clinic Abu Dhabi Experience Waqar, K.

122 C p.
artikel
139 Editorial Board
122 C p.
artikel
140 Education level and the clinical characteristics and disease progression in Huntington’s disease: An Observational and Mendelian Randomization Study Zhang, S.

122 C p.
artikel
141 EEG biosignatures are sensitive and specific markers that distinctively characterize Parkinson's Disease, Lewy Body Dementia and Alzheimer's Disease Berka, C.

122 C p.
artikel
142 Effectiveness of botulinum toxin injections into the obliquus capitis inferior muscle for spasmodic torticollis Doan, N. Luc

122 C p.
artikel
143 Effect of deep brain stimulation of the subthalamic nucleus on the executive function in Parkinson’s disease Slotwinski, K.

122 C p.
artikel
144 Effect of long-term Tai Chi training on Parkinson’s disease: A 3.5-year follow-up cohort study Li, G.

122 C p.
artikel
145 Effect of Multimodal Intensive Rehabilitation Treatment on the Optimization of Dopaminergic Therapies in Patients with Moderately Advanced Parkinson’s Disease McCrossin, M.

122 C p.
artikel
146 Effect of opicapone and entacapone on early morning-OFF pattern in Parkinson’s disease patients with motor fluctuations Videnovic, A.

122 C p.
artikel
147 Effects of aerobic interval training on motor control mechanisms in people with Parkinson’s disease Marusiak, J.

122 C p.
artikel
148 Effects of a periodic continuous theta burst stimulation in Parkinson Disease Hu, P.

122 C p.
artikel
149 Effects of Baduanjin exercise on fine motor impairment of the fingers in Parkinson's disease Li, J.

122 C p.
artikel
150 Effects of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa on Sleep Dysfunction in People With Parkinson's Hauser, R.

122 C p.
artikel
151 Effects of DLPFC tDCS followed by treadmill training on dual-task gait and cortical excitability in Parkinson's disease: A randomized controlled trial Wong, P.-L.

122 C p.
artikel
152 Effects of Periventricular White Matter Lesions on PD Cognitive Deficits are Mediated by Limbic Cholinergic Deficits in PD Carli, G.

122 C p.
artikel
153 Effects of Sleep Hygiene on Sleep Disturbance in Patients with Parkinsonism Yun, J.Y.

122 C p.
artikel
154 Efficacy and safety of foslevodopa/foscarbidopa continuous subcutaneous infusion administered as monotherapy in patients with Parkinson’s disease Aldred, J.

122 C p.
artikel
155 Efficacy and safety of foslevodopa/foscarbidopa subcutaneous infusion in patients with prior deep brain stimulation Henriksen, T.

122 C p.
artikel
156 Efficacy of Once-Daily Valbenazine in Adults with Chorea Associated with Huntington’s Disease: Effect Size Over Time Stimming, E. Furr

122 C p.
artikel
157 Elderly-onset severe parkinsonism in Wilson Disease: A case report Li, K.-F.

122 C p.
artikel
158 Electroacupuncture alleviates pain in Parkinson's disease by modulating the microglia-NLRP3 inflammasome-inflammatory factor axis Wang, X.-W.

122 C p.
artikel
159 Electroacupuncture alleviates pain in Parkinson's disease by modulating the microglia-NLRP3 inflammasome-inflammatory factors axis Wang, X.-W.

122 C p.
artikel
160 Elevated salivary copper levels in patients with Wilson's disease Bonilha, P.A.A.M.

122 C p.
artikel
161 Emerging role of rolipram in orofacial dyskinesia in a haloperidol-induced rat model via downregulation of oxidative stress and alteration in neurotransmitters Saroj, S.

122 C p.
artikel
162 Enhanced low beta activity in Park2-associated Parkinson’s disease Filyushkina, V.

122 C p.
artikel
163 Enlarged perivascular space in the temporal lobe as a predictor for cerebral amyloidosis in Lewy body disease Na, H.K.

122 C p.
artikel
164 Epidemiological Disparities and Challenges in Non-Parkinsonian Tremor Disorders Research Desai, S.

122 C p.
artikel
165 Epigenome-wide DNA methylation signatures of excessive daytime sleepiness in Parkinson's Disease: Analysis of the PPMI Cohort Yang, T.

122 C p.
artikel
166 Essential Tremor Diagnosis Accuracy: 1998 versus 2018 Movement Disorder Society Consensus Sandulescu, M.C.

122 C p.
artikel
167 Establishing exercise habits in patients with Parkinson's disease through an exercise group model LU, Y.

122 C p.
artikel
168 Estrogen Derivatives and Neuroprotection in Parkinson's Disease: A Machine Learning Analysis of Hormone Therapy Effects in Transgender Women Fajar, R.

122 C p.
artikel
169 Evaluation of autonomic, imaging and genetic biomarkers for dementia in Parkinson’s disease: A cohort description Polverino, P.

122 C p.
artikel
170 Evolution in Functionality of People with Parkinson's Disease: Gender Influence Dias, R.A.

122 C p.
artikel
171 Evolution of Cervical Dystonia (CD) Phenotypes in Patients Treated with Botulinum Toxin Trinchillo, A.

122 C p.
artikel
172 Examination of cognitive function in Parkinson's disease patients with chronic kidney disease Khudayarova, S.

122 C p.
artikel
173 Executive dysfunction, discourse deficits, and responsiveness to transcranial direct current stimulation in patients with atypical Parkinsonian disorders Scholtz, J.

122 C p.
artikel
174 Executive function in patients with Parkinson disease Slotwinski, K.

122 C p.
artikel
175 Exploration of potential immune mechanisms in cervical dystonia Scorr, Laura M.

122 C p.
artikel
176 Exploring gait-related neural activity recorded from the subthalamic nucleus in Parkinson Disease Liao, J.

122 C p.
artikel
177 Exploring Levodopa-induced dyskinesia in Latin American Parkinson`s disease patients: Insights from the large-PD Consortium Chaparro-Solano, H.M.

122 C p.
artikel
178 Exploring Mitochondrial DNA Damage in Neuronal Complex I Deficient Parkinson's Neurons Rubiolo, A.

122 C p.
artikel
179 Exploring Mitochondrial DNA Damage in Neuronal Complex I Deficient Parkinson's Neurons Rubiolo, A.

122 C p.
artikel
180 Exploring obstructive sleep apnea and sleep architecture in Parkinson's disease motor subtypes Scanga, Amanda

122 C p.
artikel
181 Exploring the clinico-ophthalmologic profile of patients with presumed genetically-determined dystonia Dhar, D.

122 C p.
artikel
182 Exploring the efficacy and challenges of Levodopa-Carbidopa Intestinal Gel in treating patients with Multiple System Atrophy: Experience of two centers Lopes, S.

122 C p.
artikel
183 Exploring the impact of antidepressants on depression in Parkinson’s disease Saxena, S.

122 C p.
artikel
184 Exploring the Role of Genetic Mutations and Clinical Features in the Conversion to α-Synucleinopathies Qin, J.

122 C p.
artikel
185 Exploring the Role of Genetic Mutations and Clinical Features in the Conversion to α-Synucleinopathies Qin, J.

122 C p.
artikel
186 Extended-release amantadine for OFF-related dystonia in Parkinson's disease Espay, Alberto J.

122 C p.
artikel
187 Extra-Striatal Cholinergic System Changes in Dopamine Replacement Therapy Responsive versus Non-Responsive Freezing of Gait in Parkinson's Disease: [18F]-FEOBV PET study Kanel, P.

122 C p.
artikel
188 Factors influencing functionality in individuals with Parkinson`s disease Libard, E.

122 C p.
artikel
189 Features of pallidal single unit activity in myoclonus dystonia Sedov, A.

122 C p.
artikel
190 Fecal microbiota transplantation for Parkinson’s disease (FMT4PD): A safety and feasibility pilot study Chernova, V.O.

122 C p.
artikel
191 Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease Zhong, H.

122 C p.
artikel
192 First-year Treatment Intensity and Prognosis in Early Parkinson’s Disease: A Retrospective, Longitudinal Study in Israel Barer, Y.

122 C p.
artikel
193 Focal task-specific hand dystonia related to esports in a rhythm gamer: A case report Kawama, K.

122 C p.
artikel
194 Frailty and autonomic insufficiency Ovchynnykova, A.

122 C p.
artikel
195 Frequency of GAA-FGF14 ataxia in a large cohort of Brazilian patients with unsolved adult-onset cerebellar ataxia Novis, L.E.

122 C p.
artikel
196 Friend or Foe? Experiences and Expectations Pertaining to the Use of Artificial Intelligence (AI) in the Field of Movement Disorders Mari, Z.

122 C p.
artikel
197 From Writer's Cramp to Blepharoclonus: An Atypical Journey with a Novel KMT2B Variant Makharia, A.

122 C p.
artikel
198 Frontotemporal dementia associated with SQSTM1 gene mutation and lower amyloid beta 1-42 Angelova, A.

122 C p.
artikel
199 Functional constipation is associated with motor response complications in Parkinson's disease Lau, Y.H.

122 C p.
artikel
200 Functional or dystonic tremor? The answer is in electrophysiological tremor recording Grneva, M.

122 C p.
artikel
201 Gait and speech improvement in one patient following 3-months of adaptive STN-DBS therapy Palmisano, C.

122 C p.
artikel
202 Gait difficulty in a young female - a rare cause should not be missed Vo, K.N.C.

122 C p.
artikel
203 GBA1-and LRRK2-directed Treatments: The Way Forward Maayan Eshed, Gadi

122 C p.
artikel
204 Gender Disparities in Parkinson's Disease: Exploring Quality of Life Among Mexican Men and Women (2011-2019) Hernández-Medrano, A.J.

122 C p.
artikel
205 Gender, Race and Socioeconomic Disparities on Initiation of Surgical Device-Aided Therapies (DATs) Among Medicare Beneficiaries with advanced Parkinson’s Disease (aPD) Fernandez, H.H.

122 C p.
artikel
206 Genetically Proven Familial Huntington’s Disease in the Philippines: A Case Series Garcia, J.J.

122 C p.
artikel
207 Genetic literacy of patients with Parkinson’s disease and their caregivers, and attitudes toward genetic testing: A review Kamath, S.

122 C p.
artikel
208 Genetic Screening in Patients with Parkinson Disease and Deep Brain Stimulation Assaedi, E.

122 C p.
artikel
209 Genetic Variability in Parkinson's Disease: A2M Gene Mutations Examined in a Cohort of 179 Patients with Familial and Early-Onset Forms Scanni, M.D.

122 C p.
artikel
210 Genetic variability of OBPIIa in Parkinson’s Disease (PD) patients of Tamil Nadu population, India Venkatesan, D.

122 C p.
artikel
211 Global presence of CSF1R-Related disorder: A case series from North and South America, Asia and Europe Dulski, J.

122 C p.
artikel
212 GNB1 mutation - A (not so) rare cause for early onset dystonia Novotni, G.

122 C p.
artikel
213 Groningen Early-PD Ambroxol Treatment (GREAT) Trial: A randomized, double-blind, placebo-controlled trial of ambroxol in Parkinson patients with a GBA-mutation (protocol) Siemeling, O.

122 C p.
artikel
214 Ground Reaction Force Analysis in Parkinson’s Disease and Freezing of Gait. A secondary analysis of a gait-analysis data set Etoom, M.

122 C p.
artikel
215 Gut changes as potential trigger for Parkinson's disease Syvänen, V.

122 C p.
artikel
216 Gut microbiota modification with rifaximin modulates severity of symptoms of Parkinson’s disease with concomitant small intestinal bacterial overgrowth Korbecka, J.

122 C p.
artikel
217 Head Position During Sleep: Potential Implications for Patients with Neurodegenerative Disorders Levendowski, D.

122 C p.
artikel
218 Healthcare education program in multiple system atrophy: Safety, quality and satisfaction from a national registry-based longitudinal study Camara, A.

122 C p.
artikel
219 Hereditary Spastic Paraparesis with SPG6 mutation: First case report from Malaysia Lau, Y.H.

122 C p.
artikel
220 High-fat diet as a predisposing factor to Parkinson disease via interplay between inflammation and autophagy in a murine model Júlio de Souza, A.L.

122 C p.
artikel
221 Hospice Guidelines for Parkinson’s Disease and Related Disorders: Lessons Learned from a Palliative Program Chan, J.

122 C p.
artikel
222 How clinicians inform patients with Parkinson’s disease about levodopa and involve them in decisions to initiate treatment Kurpershoek, E.

122 C p.
artikel
223 How to dose extended-release carbidopa-levodopa capsules (IPX203) in Parkinson’s disease patients: Experience from the phase 3 clinical trial Hauser, R.A.

122 C p.
artikel
224 ‘Hung-up’ knee jerk as an initial diagnostic clue of Huntington disease Lau, K.M.

122 C p.
artikel
225 Huntington disease – Update on ongoing therapeutic developments and a look toward the future Sampaio, Cristina

122 C p.
artikel
226 Huntington Disease – Update on Recent Advances and a Look Toward the Future Sampaio, C.

122 C p.
artikel
227 Identification of the needs of patients with Parkinson’s disease through a qualitative research process Vanchinathan, V.

122 C p.
artikel
228 If You Don’t Ask, You Won’t Know: Inclusive Recruitment Strategies for the Parkinson Progression Markers Initiative (PPMI) Mantri, S.

122 C p.
artikel
229 Iluzanebart Phase 2, IGNITE Study: First Interventional Study in Patients with Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Lynch, D.

122 C p.
artikel
230 Immersive virtual reality as a complement to physical therapy for Parkinson’s disease – A randomized controlled trial Silva, D. Pimenta

122 C p.
artikel
231 Impact of COVID-19 on Parkinson's disease: A comprehensive analysis Yuldasheva, N.

122 C p.
artikel
232 Impact of Falls on Quality of Life among Patients with Parkinson’s Disease from a Referral Center Ambulatory Care PD Clinic Yu, J.R.T.

122 C p.
artikel
233 Impact of Rivastigmine on Gait in Patients with Neurodegenerative Disorders: A Systematic Review and Meta-analysis Lee, S.-M.

122 C p.
artikel
234 Impaired contrast sensitivity performance in freezers and fallers in Parkinson’s disease Brown, T.

122 C p.
artikel
235 Implications of midbrain perivascular space in REM sleep behavior disorder and motor progression in drug-naïve Parkinson’s disease Ha, J.

122 C p.
artikel
236 Improvement of non-motor symptoms with NE3107 adjunctive to Carbidopa / Levodopa in patients with Parkinson`s disease: A Phase 2A, placebo-controlled study Palumbo, J.

122 C p.
artikel
237 Improving Quality and Safety of Care for Hospitalized People with Parkinson’s Disease – Results of Six Months of Proactive Intervention Piccinin, C.C.

122 C p.
artikel
238 Influence of electrode distance from target and stimulation current on the effect of STN-DBS Rouleau, E.A.M.Y.

122 C p.
artikel
239 Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease Mendonça, M.

122 C p.
artikel
240 Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease Mendonça, M.

122 C p.
artikel
241 Interaction between caffeine intake and polymorphisms of MCCC1 modifies Parkinson’s Disease risk Yang, Y.

122 C p.
artikel
242 Interaction between caffeine intake and polymorphisms of PARK16 modifies Parkinson’s Disease risk Tan, E.K.

122 C p.
artikel
243 Interaction between sex and GBA mutations influences clinical phenotype in Parkinson disease Gallo, L.

122 C p.
artikel
244 Interdisciplinary insights into tremor in dystonia: Navigating clinical controversies, definitional challenges, and pathophysiological complexities Shaikh, Aasef G.

122 C p.
artikel
245 Intranasal delivery of insulin for the restoration of memory signaling in Alzheimer's disease Nema, T.

122 C p.
artikel
246 Intronic GAA-FGF14 Expansion in an italian patient presenting with early-onset cerebellar ataxia Mitrotti, P.

122 C p.
artikel
247 Investigating Altered Cerebral Blood Flow Patterns in Idiopathic Cervical Dystonia: A Study Using Single Photon Emission Computed Tomography (SPECT) Kim, B.

122 C p.
artikel
248 In vivo and in vitro effects of resveratrol in experimental models of Parkinson's disease Kumar, R.

122 C p.
artikel
249 Is Dystonia an Immunologic Disorder? Jankovic, Joseph

122 C p.
artikel
250 Lack of association between ARSA rare variants and Parkinson’s disease Wang, S.

122 C p.
artikel
251 Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis Bhargava, V.

122 C p.
artikel
252 Levodopa-induced dyskinesia isolated to the abdomen in advanced Parkinson’s disease with longstanding high-dose levodopa exposure: A case report Nguyen, M.

122 C p.
artikel
253 Levodopa-responsive spastic paraparesis associated with a pathogenic variant in GCH1 Costa, S.

122 C p.
artikel
254 Lithium toxicity presented as parkinsonism and ataxia Angelova, A.

122 C p.
artikel
255 Longitudinal brain changes in Parkinson's disease with severe olfactory deficit Kawabata, Kazuya

122 C p.
artikel
256 Longitudinal change in brain function and structure related to plasma neurofilament light protein in early-stage Parkinson’s disease Xiao, Y.

122 C p.
artikel
257 Longitudinal evolution and plasma biomarkers for excessive daytime sleepiness in Parkinson's disease Lin, J.

122 C p.
artikel
258 Looking Beyond the Brain: Insights into Vascular Parkinsonism with Optical Coherence Tomography Agrawal, A.

122 C p.
artikel
259 Loss of monomeric alpha-synuclein (synucleinopenia) and the origin of Parkinson's disease Espay, Alberto J.

122 C p.
artikel
260 Low urinary tract dysfunction and motor severity in patients with multiple system atrophy Ha, U.N.L.

122 C p.
artikel
261 Machine Learning Analysis of the Interaction Between miR-155 and LRRK2 Gene Variants in Parkinson's Disease Progression Fajar, R.

122 C p.
artikel
262 Magnetic Resonance Imaging Marker for the Conversion from Idiopathic Late-onset Cerebellar Ataxia to Multiple System Atrophy Lee, J.S.

122 C p.
artikel
263 Mapping brain metabolism, connectivity and neurotransmitters topography in early and late onset dementia with lewy bodies Caminiti, Silvia Paola

122 C p.
artikel
264 MAPT c.1999-1G> A Mutation presenting as Dysexecutive variant AD with CBS phenotype Mustafa, F.

122 C p.
artikel
265 Masticatory-Induced Ocular Task-Specific Dystonia Zheng, X.

122 C p.
artikel
266 Maximum dose of AbobotulinumtoxinA: Is there room for more? Amarante, D.

122 C p.
artikel
267 Melatonin protects against Parkinson's disease via regulating the activation of NLRP3 inflammasome mediated by TLR2 Wang, X.

122 C p.
artikel
268 Mental health in Parkinson’s: Uncovering real-world patient experiences in psychological support and care Hunsdon, R.

122 C p.
artikel
269 Metabolic Syndrome and Non-Motor Symptom Fluctuations in Parkinson's Disease Regalado-Mustafa, A.Y.

122 C p.
artikel
270 Method for assessing function of the segmental apparatus of the autonomic nervous system using magnetic stimulation Radjabova, K.

122 C p.
artikel
271 Mild Behavioral Impairment in Lewy body disease: A potential marker of phenoconversion and disease severity Jin, B.

122 C p.
artikel
272 Modulation of neural activity in response to dance training in Parkinson’s: A case study Simon, R.

122 C p.
artikel
273 Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation Stampanoni Bassi, Mario

122 C p.
artikel
274 Moving Ear Syndrome: A rare and treatable phenomenon Yahya, V.

122 C p.
artikel
275 MR-guided focused ultrasound in movement disorders and beyond: Lessons learned and new frontiers Natera-Villalba, Elena

122 C p.
artikel
276 Multidimensional factors can affect the Sexual Health of men with Parkinson's disease Piemonte, M.E. Pimentel

122 C p.
artikel
277 Multidimensional factors can affect the sexual health of women living with Parkinson's disease Piemonte, M.E. Pimentel

122 C p.
artikel
278 Multiple system atrophy like presentation with hot-cross bun sign in anti-IgLON5 disease Vijayaraghavan, Asish

122 C p.
artikel
279 Muscle-targeted nutritional support and rehabilitation (MIRT) to treat Parkinsonian patients with risk of fall: A multicentric, randomized, single-blind study Frazzitta, G.

122 C p.
artikel
280 Nebulized Administration of Roasted Mucuna Powder Using a Hydrogen Water Superheated System in Parkinson's Disease Neshige, R.

122 C p.
artikel
281 Neuronal Intranuclear Inclusion Disease presenting with ataxia and parkinsonism De Santis, T.

122 C p.
artikel
282 Neuroprotective Activity of Ethanolic Extract of Sesuvium Portulacastrum Against Haloperidol Induced Parkinson’s Disease Model Rajput, R.

122 C p.
artikel
283 Neuroprotective and antioxidant potential of Moringa oleifera leaf extract in a murine model of Parkinson's disease Kumar, A.

122 C p.
artikel
284 Neuroprotective potential of nanoparticles of cinnamaldehyde on oxidative stress in nigrostriatal tissue and neurobehavioral characteristics in a rat model of Parkinson’s disease Rajput, R.

122 C p.
artikel
285 Nifedipine is identified as a potential pharmacological modulator in Parkinson's disease by an in silico electrophysiological study Mahapatra, C.

122 C p.
artikel
286 Nomogram for Predicting the Probability of Malnutrition in Parkinson's Disease Huang, Q.

122 C p.
artikel
287 Non-invasive Peripheral Vibratory Stimulation in Attenuating Essential Tremor Yan, R.

122 C p.
artikel
288 Normative modelling reveals distinct neural correlates of olfactory and cognitive impairments in patients with Parkinson's disease: A retrospective observational study Ye, R.

122 C p.
artikel
289 Novel insights into the sex-specific role of lipid and apolipoprotein traits associated with risk of Parkinson’s disease: A prospective study Zhang, S.

122 C p.
artikel
290 NOX1 triggers ferroptosis and ferritinophagy, contributing to neurodegeneration Wang, H.

122 C p.
artikel
291 Nutritional Problems and Adaptation in Persons with Parkinson’s Disease - A Qualitative Study Chen, T.-Y.

122 C p.
artikel
292 Objective clinical registration of tremor, bradykinesia, and rigidity during awake stereotactic neurosurgery Smid, A.

122 C p.
artikel
293 Observational study of Safinamide as an add-on to levodopa monotherapy for Parkinson's disease patients with wearing-off in Japan Nishikawa, N.

122 C p.
artikel
294 Occupational impact of tardive dyskinesia (TD): Survey assessing perceptions and experiences of patients with TD and physicians who treat TD Ribalov, R.

122 C p.
artikel
295 Off-the-shelf bioreactor produced, iPSC-derived neural microtissues containing dopaminergic neurons innervate the striatum and normalize behaviour in a Parkinson rat model Prudon, N.

122 C p.
artikel
296 Olfactory and Gustatory Function is Associated with Global Cognition in Early-stage Parkinson's Disease Kim, Y.E.

122 C p.
artikel
297 Olfactory subtypes in Parkinson’s disease, and their longitudinal significance Yoo, S.-W.

122 C p.
artikel
298 Opicapone as Add-on to Levodopa in Parkinson's Patients without Motor Complications: Preliminary Data from EPSILON Ferreira, J.J.

122 C p.
artikel
299 Opicapone as First-Line Strategy for the Treatment of Wearing-off in Korean Patients with Parkinson's Disease Lee, J.Y.

122 C p.
artikel
300 Opicapone as First-Line Strategy for the Treatment of Wearing-off in Patients with Parkinson's Disease Ferreira, J.J.

122 C p.
artikel
301 Opicapone Effect on Sleep Disorders in Fluctuating Parkinson’s Disease Patients: Findings from the OASIS Trial Ferreira, J.J.

122 C p.
artikel
302 Optimizing CNS-Delivery by Lactyl Stearate-Coupled Liposomes Bhargava, M.

122 C p.
artikel
303 Optimizing DBS-Programming: A Case Study with Algorithm-Guided Strategies in Parkinson's Disease Ballesteros, V. Torres

122 C p.
artikel
304 Oscillatory subthalamic cell motor responses are associated with clinical characteristics of Parkinson’s disease Nezvinskiy, A.

122 C p.
artikel
305 Painless Legs and Moving Toes Syndrome (PLMT): A Rare Case Presentation Ari, B.C.

122 C p.
artikel
306 Pallidal Deep Brain Stimulation for Patients with Idiopathic Myoclonus Dystonia without SGCE Mutation Ikezawa, J.

122 C p.
artikel
307 Parkinsonism after Bilateral Internal Globus Pallidus Deep Brain Stimulation in Dystonia Lampreia, T.

122 C p.
artikel
308 Parkinson's disease and its financial impact on the Brazilian public health system Falcão, M. Fortaleza

122 C p.
artikel
309 Parkinson’s Disease Management in a Tertiary Irish Hospital Gibbons, C.

122 C p.
artikel
310 Parkinson’s Disease Psychosis: A systematic review of pharmacological treatment Costandache, G.

122 C p.
artikel
311 Parkinson's Disease Social Stigma Perception Scale (PDSP): Development and Pilot Study Of A Measurement Scale Guerra-Anzaldo, A.L.

122 C p.
artikel
312 Parkinson’s Disease with Hyposmia and Dysautonomia: Does It Represent a Distinct Subtype? Yoon, S.H.

122 C p.
artikel
313 Parkinson’s Disease with Hyposmia and Dysautonomia: Does It Represent a Distinct Subtype? Yoon, S.H.

122 C p.
artikel
314 Patient characteristics and real-world use of botulinum toxins for treatment of cervical dystonia and blepharospasm Hast, M.

122 C p.
artikel
315 Patient characteristics and real-world use of botulinum toxins for treatment of chronic sialorrhea Hast, M.

122 C p.
artikel
316 Patient characteristics and real-world use of botulinum toxins for treatment of hemifacial spasm Hast, M.

122 C p.
artikel
317 Patient Involvement in Parkinson’s Disease Research: Involving People with PD in the Development of a Digital Self-Management Tool Olgemöller, P.M.

122 C p.
artikel
318 Persons with Parkinson`s disease show the motor behavioral phenomenon repeated bout rate enhancement during cycling Hansen, E.A.

122 C p.
artikel
319 Pharmacist consultation in patients with Parkinson’s Disease in the outpatient clinic Akkerman, M.M.

122 C p.
artikel
320 Phenotypic characterization of Multiple System Atrophy in a multi-ethnic Asian cohort Dy Closas, A.M.

122 C p.
artikel
321 Phenotypic manifestations of KIF5A Arg1007Lys mutation: A large kindred study Dulski, J.

122 C p.
artikel
322 Phenotypic variability among siblings with heterozygous VPS13A variants Lee, S.

122 C p.
artikel
323 Phospholipase-associated neurodegeneration in India: Observations from a case series of 20 patients Garg, D.

122 C p.
artikel
324 Physical exercise as a promising enhancer of global cognition in people with Parkinson’s disease? A systematic review and meta-analysis Folkerts, A.-K.

122 C p.
artikel
325 Physiological effects of dual target DBS in an individual with Parkinson's disease and a sensing-enabled pulse generator Cummins, Daniel D.

122 C p.
artikel
326 Pimavanserin for Psychosis in Parkinson’s Disease Dementia: Subgroup Analysis of the HARMONY Trial Weintraub, D.

122 C p.
artikel
327 Plasma neurofilament light chain level in isolated REM sleep behavior disorders, Parkinson’s disease and multiple system atrophy Calculli, A.

122 C p.
artikel
328 Plasma proteomic profiles and risk of Parkinson's disease Li, C.

122 C p.
artikel
329 Population pharmacokinetic analysis of BIA 28-6156, an allosteric activator of beta-glucocerebrosidase (GCase), in Parkinson’s Disease patients and healthy volunteers Ronaghinia, A.A.

122 C p.
artikel
330 “Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention Sathe, S.

122 C p.
artikel
331 Posterior cortical atrophy with biomarkers of Alzheimer's disease presenting with corticobasal syndrome and Balint syndrome - A case report Vo, K.N.C.

122 C p.
artikel
332 Predicting Impulsivity in Parkinson’s Disease Patients Chen, S.

122 C p.
artikel
333 Predicting the optimal deep brain stimulation contact-level in Parkinson's disease: Insights from local field potentials recorded by the implanted neurostimulator Muller, M.

122 C p.
artikel
334 Pregnancy in dystonia or Tourette’s patients treated with DBS. Four new cases and a review of the literature Mehanna, R.

122 C p.
artikel
335 Prevalence of Autonomic Symptoms in a Mexican Population with Parkinson's Disease Dominguez-Garcia, A.

122 C p.
artikel
336 Prevalence of non-motor symptoms and their impact on quality of life in PD: A Mexican Registry, 2011-2019 (the ReMePark-2 study) Romero Terán, D.P.

122 C p.
artikel
337 Prevalence of tardive dysmentia & tardive dyskinesia in patients with schizophrenia Nayak, M.

122 C p.
artikel
338 Processing Speed Mediates the Relationship between Apathy and Emotion Recognition in Parkinson’s Disease Zabala-Gomez, O.

122 C p.
artikel
339 Prodromal and Overt Parkinson’s Disease Epidemiological Study in Brazil (PROBE-PD study): Preliminary Results Pedrosa, L.R.R.

122 C p.
artikel
340 Profile of Glucocerebrosidase 1 (GCASE) activity and Glucosylsphingosine levels in GBA-PD, PD patients and healthy volunteers Pires, N.

122 C p.
artikel
341 Profile of patients with advanced Parkinson’s disease treated with Levodopa–entacapone–carbidopa intestinal gel (LECIG) Szász, J.

122 C p.
artikel
342 Progressive Encephalomyelitis with Rigidity and Myoclonus in a Varicella Encephalitis patient with Primary Meige syndrome Jayasree, M.

122 C p.
artikel
343 Progressive Encephalomyelitis with Rigidity and Myoclonus In a Varicella Encephalitis Patient with Primary Meige syndrome Jayasree, M.

122 C p.
artikel
344 Progressive QTc prolongation and reduced heart rate variability in dementia with Lewy bodies compared to Alzheimer's disease Haglund, Mattias

122 C p.
artikel
345 Protective potential of laughter yoga and clapping exercises on stress level and motor functions in Parkinson’s disease patients with type 2 diabetes Kumar, R.

122 C p.
artikel
346 Psychometric Validation of the Mild Behavioral Impairment Checklist (MBI-C) in Parkinson’s Disease Pinilla-Monsalve, G.D.

122 C p.
artikel
347 Psychomotor delay: Expanding the neurological phenotype of ATP13A2-related disorders Silva, L.

122 C p.
artikel
348 QI Project introducing A Reflective-Education Model Optimizing Palliative Care Delivery: A Multidisciplinary and Primary Care Integration Model Bacorro, M.

122 C p.
artikel
349 Quality of Life in Parkinson’s Disease: Examining the Influence of the Intersection between Health-Related Quality of Life and Clinical Metrics Kuanar, G.

122 C p.
artikel
350 Quebec Parkinson Network: The reference for your next research in Parkinson's disease and related disorders Bogard, S.

122 C p.
artikel
351 Recent advances in non-Huntington's disease choreas Cincotta, Molly C.

122 C p.
artikel
352 Recrudescence of a compensated hemidystonia-hemiatrophy syndrome after COVID-19 infection Kundrick, A.

122 C p.
artikel
353 Refining the clinical diagnosis of Parkinson's disease Mulroy, Eoin

122 C p.
artikel
354 Relation between Clinical and Electrophysiological Correlates of Peripheral Polyneuropathy and Oral Levodopa Treatment in People with Parkinson’s Disease Déry, C.

122 C p.
artikel
355 Relationship between agricultural vulnerability to organic compound fungicides and herbicides and Parkinson's disease incidence in a rural population in northern India Sharma, M.

122 C p.
artikel
356 Retro-Walking and Cholinergic System Changes in Parkinson's Disease Griggs, A.

122 C p.
artikel
357 Rheumatoid Arthritis and Risk of Parkinson’s disease in the UK Biobank: A Prospective Study Zheng, X.

122 C p.
artikel
358 Right Default Mode Network Functional Instability Predicts Poorer Executive Function in Parkinson’s Disease Roytman, S.

122 C p.
artikel
359 Right to the Point - A Writer’s Cramp Successful Treatment Duarte, A.

122 C p.
artikel
360 Risk factors for Parkinson's disease and Parkinson's disease with cognitive impairment in high altitude: A case-control study Zhu, A.

122 C p.
artikel
361 Risk of developing Parkinson's disease and early stage diagnosis through the primary healthcare system Akramova, D.

122 C p.
artikel
362 Role of estrogen and progesterone on neuronal parameters and behavioral impairments in different age groups of naturally menopausal rats: A behavioral, biochemical and ultrastructural study Kumar, P.

122 C p.
artikel
363 Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups. Kumar, P.

122 C p.
artikel
364 Role of pharmacological therapy on bone mineral density and postural instability in post-menopausal women with Parkinson’s disease Rajput, R.

122 C p.
artikel
365 Role of telemedicine- versus outpatient-based initiation and management of Atkins diet therapy in middle aged women with drug-resistant Parkinson's disease during the COVID-19 pandemic Sharma, M.

122 C p.
artikel
366 Role Of Wearable Technology And Geo-Fencing Device For Analyses of Movement And Memory Data In Huntington's Disease Patients In Gurugram City, India Sharma, V.

122 C p.
artikel
367 Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-Month Results From a Phase 1 Study Fasano, A.

122 C p.
artikel
368 Saving dopaminergic neurons from endoplasmic reticulum (ER) stress - A breakthrough approach to fight Parkinson's disease Gentile, L.

122 C p.
artikel
369 SCA4: Correlation of age of onset and ZFHX3 repeat length Wallenius, J.

122 C p.
artikel
370 Selective Brain Iron Deposition in Individuals with a History of Methamphetamine Abuse Kelley, L.

122 C p.
artikel
371 Sexual dysfunction in patients with focal dystonia Kalniņa, M.

122 C p.
artikel
372 Should Serum NMO Antibody Testing Be Part Of The Initial Work-up In Adult Onset Cerebellar Ataxia Tar, M.

122 C p.
artikel
373 Singing training in people with Parkinson's disease: A feasibility study Trinchillo, A.

122 C p.
artikel
374 Sleep Biomarker-Based Characterization of Neurodegenerative Disorder Risk in Parkinsonian Spectrum Disorder Patients Levendowski, D.

122 C p.
artikel
375 Sleep disturbances are associated with accelerated postural instability and death in Parkinson’s disease Griti, S.A.

122 C p.
artikel
376 Somnolence-Related Events Over Time During Valbenazine Treatment for Chorea Associated with Huntington’s Disease Stimming, E. Furr

122 C p.
artikel
377 Specific features of behavioral disorders in Parkinson's disease Naimov, O.

122 C p.
artikel
378 Spectrum of movement disorders, imaging findings in SSPE and response to therapy – A prospective cohort study Elavarasi, A.

122 C p.
artikel
379 Speech Biomarkers for Dysarthria in Parkinson's Disease — Clinical Validation Across Spanish and Czech Languages Baykara, E.

122 C p.
artikel
380 Spinocerebellar ataxia type 3 (MJD) without distinct parkinsonism showing presynaptic dopamine transporter (DAT) uptake loss Park, M.

122 C p.
artikel
381 Sporadic Creutzfeldt-Jakob disease: A Retrospective Analysis of 27 cases in Vietnam Bui, N.

122 C p.
artikel
382 Start Right, Stay Well: Piloting a Screening Tool for Dysphagia and Medication Management for Patients with Parkinson's in the Emergency Department Hornby, H.

122 C p.
artikel
383 STAT3-mediated ferroptosis is involved in α-synuclein pathology Lin, D.

122 C p.
artikel
384 Striatal dopaminergic degeneration and motor and cognitive symptoms in de novo Parkinson’s Disease: An 18F-DOPA PET study De Meyer, E.

122 C p.
artikel
385 Structural correlates of survival in progressive supranuclear palsy Street, D.

122 C p.
artikel
386 Studying the relationship between different stages of Parkinson's disease and iron metabolism, oxidative stress, and inflammation from Qinghai-Tibetan Plateau Area Yan, L.

122 C p.
artikel
387 Study of 17β estradiol with neuropeptide and amyloid beta fragment on neuronal and biochemical functions in naturally menopausal aging rats Kumar, P.

122 C p.
artikel
388 Study of the Neuroprotective Potential of gallic acid in the Mouse Model of Parkinson’s Disease Rajput, S.

122 C p.
artikel
389 Study protocol: Exploration of sternal focused vibrotactile stimulation in people with Parkinson's disease experiencing Freezing of Gait Wilhelm, A.

122 C p.
artikel
390 Subthalamic activity in Park2-associated early-onset Parkinson’s disease Pavlovsky, P.

122 C p.
artikel
391 Suicide Attempt in a Case of Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease Espindola, M.

122 C p.
artikel
392 Sustained release triple drug loaded Colloidosomes for management of Parkinson’s Disease Bhargava, S.

122 C p.
artikel
393 Systemic inflammation and the risk of multiple system atrophy: A prospective cohort study Zhang, S.

122 C p.
artikel
394 Tai Chi improves non-motor symptoms of Parkinson's disease: One-year randomized controlled study with the investigation of mechanisms Li, G.

122 C p.
artikel
395 Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease van Emde Boas, M.

122 C p.
artikel
396 Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease van Emde Boas, M.

122 C p.
artikel
397 TeleHD: Feasibility, Validity and Value of Telemedicine in Huntington Disease Deliz-Gonzalez, J.

122 C p.
artikel
398 Telehealth Follow-up for Cervical Dystonia Patients Treated with Neurotoxin Injection: Patient Reported Outcomes Harper, K.

122 C p.
artikel
399 Testing gene-environment interaction in PD using whole-genome sequencing (WGS) of pesticide-exposed cohorts Goldman, S.

122 C p.
artikel
400 TGF-β1 Provides Neuroprotection via Inhibition of Microglial Activation in 3-Acetylpyridine-Induced Cerebellar Ataxia Model Rats Cao, B.-B.

122 C p.
artikel
401 The association of olfactory dysfunction with depression in patients with early-onset Parkinson`s disease Thi Huyen, T. Dang

122 C p.
artikel
402 The association of olfactory dysfunction with depression in patients with early-onset Parkinson`s disease Thi Huyen, T. Dang

122 C p.
artikel
403 The Association of Radiological Features to Predominant Cognitive Clinical Syndromes of Lewy Body Dementia Uyanik, O.

122 C p.
artikel
404 The brain fMRI study of patients with Parkinson's disease and pain induced by contact heat stimulations Qiao-Jun, P.

122 C p.
artikel
405 The characteristic and prognostic role of blood inflammatory markers in patients with Huntington's disease from China Cheng, Y.

122 C p.
artikel
406 The Characteristics of Autonomic Dysfunction in Progressive Supranuclear Palsy: A Retrospective Study Wang, Y.

122 C p.
artikel
407 The cingulate island sign in a mixed memory clinical cohort: Prevalence and diagnostic accuracy Feng, Linda Ruohua

122 C p.
artikel
408 The clinical features, neuroimaging and outcomes of diabetic striatopathy: A retrospective study at a tertiary hospital in Vietnam Nguyen, N.

122 C p.
artikel
409 The Correlation between Nutritional Status and Quality of Life in Persons with Parkinson’s disease Ouyang, C.-M.

122 C p.
artikel
410 The effect of intraoperative monitoring on final electrode placement in movement disorder patients treated with deep brain stimulation Ibrulj, S.

122 C p.
artikel
411 The efficacy of Safinamide in improving motor symptoms and the quality of life in Korean patients with motor fluctuations Kwon, D.-Y.

122 C p.
artikel
412 The Elevated Risk of Dementia in Parkinson's Disease Patients Associated with Metabolic Syndrome Tur, E. Kobak

122 C p.
artikel
413 The feasibility of sequential remote motor evaluations of people with possible Parkinson’s disease and related conditions Elshourbagy, A.

122 C p.
artikel
414 The greater loss of ability to detect unpleasant smells may be related to the risk of more severe PD symptoms Chiu, S.-C.

122 C p.
artikel
415 The impact of short-term blood pressure variability on dementia in Parkinson’s disease in relation to the renin-angiotensin system Kwasniak-Butowska, M.

122 C p.
artikel
416 The influence of robotics and modern technologies to assist individuals with Parkinson's disease Kim, A.

122 C p.
artikel
417 The Link between COVID-19 and Parkinsonism: A Case Series Khalid, S.H.

122 C p.
artikel
418 The long-term response to botulinum toxin injections in patients with blepharospasm undergoing upper eyelid surgery Trinchillo, A.

122 C p.
artikel
419 The PD-HI: Development and Validation of a Novel, Disease-Specific Patient-Reported Outcome Measure for Parkinson’s Disease Clinical Trials Seabury, J.

122 C p.
artikel
420 The phenotypic spectra of polyQ expansion versus non-expansion forms in spinocerebellar ataxias Moura, J.

122 C p.
artikel
421 The phosphodiesterase inhibitor, ibudilast ameliorates Huntington's disease pathology by modulating neuroinflammation and signaling pathway in a rat model Kumar, A.

122 C p.
artikel
422 The potential use of plasma GFAP as a diagnostic and prognostic biomarker of motor subtype in early Parkinson’s disease Che, N.

122 C p.
artikel
423 Therapeutic benefit of laughter yoga and deep breathing exercises with oral doses of Withania somnifera root extracts in Parkinson's disease patients. Kumar, R.

122 C p.
artikel
424 Therapeutic effects of hyperbaric oxygen on Parkinson disease - A systematic review and meta-analysis. Zhao, Q.

122 C p.
artikel
425 The role of brain-derived neurotrophic factor during Parkinson's disease Holmuratova, B.

122 C p.
artikel
426 The role of neurotrophic factors in development Parkinson's disease dementia Okhunova, D.

122 C p.
artikel
427 The role of Parkin for neuroprotection in TAF15-induced proteinopathy Choi, E.J.

122 C p.
artikel
428 The role of semispinalis capitis muscles in cervical dystonia with goose-neck posture Vu, H.

122 C p.
artikel
429 The significance of mineral mass imbalances in cognitive dysfunctions associated with vascular parkinsonism Akramova, D.

122 C p.
artikel
430 Theta-alpha STN oscillations are associated with motor signs of Parkinson’s disease Sayfulina, K.

122 C p.
artikel
431 The use of botulinum toxin A in the treatment of hand tremor Peshkin, A.

122 C p.
artikel
432 The use of diffusion tensor tomography (DTI) to assess the recovery of Pyramidal system Peshkin, A.

122 C p.
artikel
433 The vestibulospinal dysfunction has little impact on falls in patients with mild Parkinson's disease Hong, Jun-Pyo

122 C p.
artikel
434 Time perception reflects individual differences in motor and non-motor symptoms of Parkinson’s disease Kishida, K.

122 C p.
artikel
435 TMEM106B aggravates symptoms of Parkinson’s disease by regulating the autophagy-lysosome pathway Xie, A.

122 C p.
artikel
436 TMEM106B knockdown exhibits a neuroprotective effect in Parkinson’s disease via decreasing inflammation and iron deposition Liu, Y.

122 C p.
artikel
437 Topography of cholinergic system changes associated with visuomotor-cognitive multitasking simulating real-life mobility in Parkinson’s disease Biddix, A.

122 C p.
artikel
438 TorsinA-interacting protein 2 (TOR1AIP2) variants in an autosomal dominant combined dystonia-hemichorea-hemiballismus syndrome in two families Kafantari, E.

122 C p.
artikel
439 Total Physical Activity, Plant-based Diet and Neurodegenerative Diseases: A Prospective Cohort Study of the UK Biobank Zheng, X.

122 C p.
artikel
440 To test or not to test: Assessing olfaction in Parkinson’s disease based on patient reports Sari, H.K.

122 C p.
artikel
441 Towards a biological diagnosis of PD Chopra, Avika

122 C p.
artikel
442 Trajectory of Motor progression pursuant to temporal dynamic status of cardiac denervation in Parkinson’s disease Yoo, S.-W.

122 C p.
artikel
443 Trajectory of Motor progression pursuant to temporal dynamic status of cardiac denervation in Parkinson’s disease Yoo, S.-W.

122 C p.
artikel
444 Transformation of clinical forms and stages of Parkinson's disease against the background of Covid-19 infection Matmurodov, R.

122 C p.
artikel
445 Treatment of Hemimasticatory Spasm and Facial Myokymia Associated with Hemifacial Atrophy and Localized Morphea with Botulinum Neurotoxin and Immunotherapy Mustafa, F.

122 C p.
artikel
446 Treg Cells Attenuate Neuroinflammation and Protect Neurons in a Mouse Model of Parkinson's Disease Huang, Y.

122 C p.
artikel
447 TREM2 deficiency aggravates neuroinflammatory response and cognitive impairment via disease-associated microglia in Parkinson’s disease Zhang, P.

122 C p.
artikel
448 Two parallel nigrostriatal subcircuits mediate arousal effect of dopaminergic neurons in substantia nigra pars compacta Liu, H.

122 C p.
artikel
449 Unawareness of hyposmia in people with and without Parkinson`s disease Thi Huyen, T. Dang

122 C p.
artikel
450 Understanding Fall Perceptions Among People with Parkinson’s Disease: A Systematic Qualitative Review Ng, Q.X.

122 C p.
artikel
451 Understand the connection between oxidative stress levels and mitochondrial gene mutations in Parkinson’s disease patients Balachandar, M.

122 C p.
artikel
452 Unraveling the Diagnostic Enigma: Stiff Person Syndrome or axial dystonia? Jacheva, I.

122 C p.
artikel
453 Unraveling the Genetic Landscape of Undiagnosed Cerebellar Ataxia in Brazilian Patients Novis, L.E.

122 C p.
artikel
454 Unusual rapid progression of cognitive function in young-onset Parkinson’s disease: A case report Tsuboi, R.

122 C p.
artikel
455 Unveiling Cholinergic Brain changes associated with Visuo-Constructive Deficits in Parkinson's Disease: A Focus on the Hooper Test van Emde Boas, M.

122 C p.
artikel
456 Unveiling the Complexity of Parkinson's Disease: Exploring Subtypes and Tracing its Five-Stage Natural Course Abduraimov, K.

122 C p.
artikel
457 Updates in essential tremor Okelberry, Tyler

122 C p.
artikel
458 Ups and Downs, Joys and Sorrows: Assessing Patient Priorities in an Interdisciplinary PD Clinic Trahair, E.

122 C p.
artikel
459 Usage of modern technologies like VR therapy, physio therapy along with levodopa in Young-Onset Parkinson's disease patients Pavihran, D.

122 C p.
artikel
460 User-Centric Design of a Biochemical Sensor for Parkinson's Disease: A Survey-Based Approach to Understand Community Expectations and Values Dupre, B.

122 C p.
artikel
461 Validation of GWAS-Identified Risk Loci for Parkinson’s Disease in the Chinese Population Li, C.

122 C p.
artikel
462 Validation of models for assessing eligibility for referral for Device-Aided Treatment in Parkinson's disease (VALIDATE) Moes, H.

122 C p.
artikel
463 Validation of Strategies for Measuring Blood Glucocerebrosidase Enzyme Activity in Parkinson's Disease with GBA1 Variant Park, K.-S.

122 C p.
artikel
464 Validation of the Polish Version of the Gastrointestinal Dysfunction Scale for Parkinson's Disease Nowak, J.M.

122 C p.
artikel
465 Variations in total body fluid and mineral mass in different forms of Parkinson`s disease Akramova, D.

122 C p.
artikel
466 Vascular remodeling in patients with CKD as a risk factor for the development of vascular Parkinsonism Khudayarova, S.

122 C p.
artikel
467 Wait and see... is it multiple system atrophy type C? A case report Grilo, P.

122 C p.
artikel
468 When Jerks and Stumbles Become More Than Just Clumsiness Desai, S.

122 C p.
artikel
469 Whole exome sequencing and clinical investigation of young onset dystonia: What can we learn? Park, J.

122 C p.
artikel
470 Withdrawn
122 C p.
artikel
471 Withdrawn
122 C p.
artikel
472 Withdrawn
122 C p.
artikel
473 WITHDRAWN
122 C p.
artikel
474 Withdrawn
122 C p.
artikel
                             474 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland